NCT03565848

Brief Summary

Colorectal resection is a standard surgical treatment of bowel deep infiltrating endometriosis (DIE). Nevertheless, concerns about different bowel functional outcomes related to radical surgery versus conservative surgery as shaving technique is a topic leading to much debate. Different surgical approach are used to perform colorectal resection and there is not a standardized technique. For the same concerns, studies have addressed the mesenteric vascular and nerve preservation both in oncological and benign intestinal disease with improved functional outcome. Therefore, the aim of this prospective study is to analyze feasibility and safety of mesenteric vascular and nerve Sparing Surgery in laparoscopic segmental colorectal resection for DIE with short and long term follow up. Women with DIE ,that underwent laparoscopic segmental colorectal resection, will undergo resection performed with inferior mesenteric artery and branching arteries preservation by dissecting adherent to the intestinal wall with mesenteric vascularization and innervation entirely preserved. Personal history, clinical data, surgical data, short and long term surgical complications and long term outcomes will be recorded. Symptoms and bowel function will be evaluated before and after surgery.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2022

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 30, 2018

Completed
22 days until next milestone

First Posted

Study publicly available on registry

June 21, 2018

Completed
3.9 years until next milestone

Study Start

First participant enrolled

May 1, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

September 30, 2021

Status Verified

September 1, 2021

Enrollment Period

1 year

First QC Date

May 30, 2018

Last Update Submit

September 28, 2021

Conditions

Keywords

LaparoscopyColorectal resectionDeep infiltrating endometriosisConstipation

Outcome Measures

Primary Outcomes (6)

  • Change in endometriosis related dysmenorrhea evaluated by Numeric Rating Scale for Pain

    Dysmenorrhea in 0 - 10 range according to the Numeric Rating Scale for Pain

    Change from baseline dysmenorrhea at 60 days after surgery and at 1 year after surgery

  • Change in endometriosis related dyschezia evaluated by Numeric Rating Scale for Pain

    Dyschezia in 0 - 10 range according to the Numeric Rating Scale for Pain

    Change from baseline dyschezia at 60 days after surgery and at 1 year after surgery

  • Change in endometriosis related dyspareunia evaluated by Numeric Rating Scale for Pain

    Dyspareunia in 0 - 10 range according to the Numeric Rating Scale for Pain.

    Change from baseline dyspareunia at 60 days after surgery and at 1 year after surgery

  • Change in endometriosis related dysuria evaluated by Numeric Rating Scale for Pain

    Dysuria in 0 - 10 range according to the Numeric Rating Scale for Pain.

    Change from baseline dysuria at 60 days after surgery and at 1 year after surgery

  • Change in endometriosis related pelvic chronic pain evaluated by Numeric Rating Scale for Pain

    Pelvic chronic pain in 0 - 10 range according to the Numeric Rating Scale for Pain.

    Change from baseline pelvic chronic pain at 60 days after surgery and at 1 year after surgery

  • Change in bowel symptoms evaluated by Constipation Assessment Scale

    Bowel symptoms in 0 - 16 range according to the Constipation Assessment Scale. Constipation Assessment Scale includes eight items, each of which is self-rated by the patient as 'no problem' (score of 0), 'some problem' (score of 1), or 'severe problem' (score of 2). The item ratings are then summed, so the overall score may range from 0 (no constipation) to 16 (worst possible constipation).

    Change from baseline bowel symptoms at 60 days after surgery and at 2 year after surgery

Secondary Outcomes (2)

  • Endometriosis characteristics

    intraoperative

  • Complication rate

    Within 6 months after surgery

Study Arms (1)

Women underwent colorectal resection for endometriosis

Women referred for colorectal resection for deep infiltrating endometriosis that underwent laparoscopic segmental colorectal resection performed with mesenteric vascular and nerve sparing surgery.

Procedure: Mesenteric vascular and nerve sparing surgery in laparoscopic segmental colorectal resection

Interventions

Laparoscopic segmental colorectal resection performed by dissecting adherent to the intestinal wall with mesenteric vascularization and innervation entirely preserved.

Women underwent colorectal resection for endometriosis

Eligibility Criteria

Age20 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women with deep infiltrating endometriosis underwent laparoscopic surgery treatment with segmental intestinal resection.

You may qualify if:

  • Patients referred for bowel endometriosis requiring colorectal resection

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

EndometriosisConstipation

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Simone Garzon, M.D.

    Universita di Verona

    PRINCIPAL INVESTIGATOR
  • Antonio Simone Laganà, M.D.

    Uninsubria

    PRINCIPAL INVESTIGATOR
  • Paola Pomini, M.D.

    Universita di Verona

    PRINCIPAL INVESTIGATOR
  • Massimo Franchi, M.D.

    Universita di Verona

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

May 30, 2018

First Posted

June 21, 2018

Study Start

May 1, 2022

Primary Completion

May 1, 2023

Study Completion

May 1, 2024

Last Updated

September 30, 2021

Record last verified: 2021-09